BRAF and neurofibromatosis type 1: Shibahara et al reported GBM in 4 NF1 patients without IDH1, BRAF V600E, and TERT promoter mutations.[12] All of them harboured intracranial well-circumscribed tumor and received surgical resection and concurrent chemoradiotherapy.